04 Mar, 2026 First-in-Human Use of CereVasc® eShunt® System in Idiopathic Intracranial Hypertension Demonstrates Sustained Clinical Outcomes Carlos Bonilla2026-06-02T13:12:28+00:00March 4th, 2026| Read More
